Research and Markets: Innovations in Injectables: Current and Emerging Technologies to Improve Drug Delivery

Research and Markets (http://www.researchandmarkets.com/research/fc70ad/innovations_in_inj) has announced the addition of the "Innovations in Injectables: Current and Emerging Technologies to Improve Drug Delivery" report to their offering.

The drug delivery market is a rapidly evolving force in the pharmaceutical industry. Within this segment injectables have a significant role to play at present with the increasing use of proteins and peptides. Although a relatively underdeveloped market at present the injectable drug delivery has a substantial pipeline, and with significant strides in development of nanotechnology and DNA drug delivery over the past 5 years, injectable drug delivery is set to be an important component of the future pharmaceutical landscape.

This report evaluates the current and evolving technologies used for injectable drug delivery, the key therapeutic areas, the barriers and driving forces for this market, the competitive landscape is analysed according the technology type, and key pipeline companies and products are examined. Leading companies in the injectable drug delivery market are also profiled.

Key Market Issues

• Injectable drug delivery has a significant potential to drive the future market, however, at present only a few key products have enjoyed significant market success.
• Nanotechnology and DNA drug delivery are set to shape future markets significantly, both have a very strong pipeline, but DNA delivery has yet to have any proven market success.
• Therapy areas where adherence is a significant problem area present a major area of opportunity for injectable delivery. Current key market successes such as Risperdal Consta demonstrate the role that injectable delivery has to play in overcoming adherence problems, and future potential in areas such as mental health, diabetes and HIV are set to ensure the continued success of injectable delivery.

Key findings from this report

• The injectable drug delivery market holds great potential but is still in its infancy. Successes so far are dominated by just a few products.
• The injectable delivery pipeline is very strong and disproportionate at present to the current market, suggesting it may have a much more significant influence on the future market with the increased use of proteins and peptides.
• DNA technology is yet to prove successful, despite significant investment and research there has been only 1 successful marketed product, which has not achieved great market success.
• Nanotechnology holds the greatest potential for success in the near future. Current products enjoy some increasing success and there is a strong pipeline with products in high revenue therapy areas.
• Although sustained release products will continue to be used, there is little development in this field with a greater move towards nanotechnology and DNA drug delivery.

Key Topics Covered:

• Innovations in injectables
• Chapter 1 Introduction
• Chapter 2 Key areas for injectable drug delivery
• Chapter 3 Market drivers and resistors
• Chapter 4 Competitive landscape
• Chapter 5 Company profiles of key players
• Chapter 6 Conclusions
• List of Figures
• List of Tables

Companies Mentioned:

• Alkermes
• Bioject
• Debiopharm
• Elan Drug Technologies
• Enzon
• Ferring International
• Nektar
• QLT

For more information visit http://www.researchandmarkets.com/research/fc70ad/innovations_in_inj

Source: Business Insights